BSTC - Biospecifics Technologies Corp.
Close
88.53
0.130 0.147%
Share volume: 356,246
Last Updated: Tue 01 Dec 2020 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$88.40
0.13
0.15%
Summary score
58%
Profitability
79%
Dept financing
1%
Liquidity
41%
Performance
56%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
4.91%
Return on assets
5.88%
Return on sales
0%
Return on invested capital
28.31%
Total debt ratio
5.49%
Debt ratio change over timeo
-0.85%
Current Ratio
43.76%
Quick Ratio
0%
Cash Position Ratio
4.99%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
4.46%
Return on assets
5.53%
Return on sales
0%
Return on invested capital
42.02%
Total debt ratio
2.04%
Debt ratio change over timeo
-0.96%
Current Ratio
59.92%
Quick Ratio
0%
Cash Position Ratio
3.7%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
3.98%
Return on assets
4.74%
Return on sales
0%
Return on invested capital
16%
Total debt ratio
1.42%
Debt ratio change over time
-0.98%
Current Ratio
66.23%
Quick Ratio
0%
Cash Position Ratio
1.86%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-90.67%
Return on assets
-88.04%
Return on sales
0%
Return on invested capital
-18.07%
Total debt ratio
-85.25%
Debt ratio change over time
-0.85%
Current Ratio
73.94%
Quick Ratio
0%
Cash Position Ratio
6.84%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BSTC | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 4.91% | 0% | 0% | 26.83% |
| Return on assets | 5.88% | 0% | 0% | -10.24% |
| Return on sales | 0% | 0% | 0% | -1670.47% |
| Return on invested capital | 28.31% | 0% | 0% | 57.71% |
| Profitability | 67% | 0% | 0% | 50% |
| Total debt ratio | 5.49% | 0% | 0% | 168.24% |
| Debt ratio change over time | -0.85% | 0% | 0% | 17.84% |
| Dept financing | 1% | 0% | 0% | 50% |
| Current Ratio | 59.92% | 0% | 0% | 8.32% |
| Quick Ratio | 0% | 0% | 0% | 8.32% |
| Cash Position Ratio | 3.7% | 0% | 0% | 7.97% |
| Liquididy | 50% | 0% | 0% | 50% |
| Short-term ratios | BSTC | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 4.46% | 0% | 0% | -39.65% |
| Return on assets | 5.53% | 0% | 0% | -13.45% |
| Return on sales | 0% | 0% | 0% | -4352.39% |
| Return on invested capital | 42.02% | 0% | 0% | 120.66% |
| Profitability | 84% | 0% | 0% | 25% |
| Total debt ratio | 2.04% | 0% | 0% | 65.53% |
| Debt ratio change over time | -0.96% | 0% | 0% | 0.08% |
| Dept financing | 1% | 0% | 0% | 50% |
| Current Ratio | 59.92% | 0% | 0% | 8.32% |
| Quick Ratio | 0% | 0% | 0% | 8.32% |
| Cash Position Ratio | 3.7% | 0% | 0% | 7.97% |
| Liquididy | 37% | 0% | 0% | 53% |